These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20874698)

  • 1. Meningococcal disease and future drug targets.
    Gammelgaard LK; Colding H; Hartzen SH; Penkowa M
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):140-5. PubMed ID: 20874698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine].
    Turhan V; Acar A; Kılıç A; Budak S; Oncül O; Haznedaroğlu T; Görenek L
    Mikrobiyol Bul; 2010 Jul; 44(3):473-8. PubMed ID: 21063998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and pathogenesis of Neisseria meningitidis.
    Tzeng YL; Stephens DS
    Microbes Infect; 2000 May; 2(6):687-700. PubMed ID: 10884620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease.
    Abramson JS; Spika JS
    J Infect Dis; 1985 Feb; 151(2):370-1. PubMed ID: 3918127
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial peptide resistance in Neisseria meningitidis.
    Tzeng YL; Stephens DS
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3026-31. PubMed ID: 26002321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiology. A furtive pathogen revealed.
    Nassif X
    Science; 2000 Mar; 287(5459):1767-8. PubMed ID: 10755929
    [No Abstract]   [Full Text] [Related]  

  • 8. Invasive meningococcal disease: a disease of the endothelial cells.
    Coureuil M; Bourdoulous S; Marullo S; Nassif X
    Trends Mol Med; 2014 Oct; 20(10):571-8. PubMed ID: 25178566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe meningococcal infection: a review of epidemiology, diagnosis, and management.
    Campsall PA; Laupland KB; Niven DJ
    Crit Care Clin; 2013 Jul; 29(3):393-409. PubMed ID: 23830646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Overview of Neisseria meningitidis.
    Hollingshead S; Tang CM
    Methods Mol Biol; 2019; 1969():1-16. PubMed ID: 30877666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Failure of antibiotic therapy of epidemic cerebrospinal meningitis].
    Kostrzewski JM
    Wiad Lek; 1980 Dec; 33(23):1923-5. PubMed ID: 6787809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiology and therapy of infections caused by Neisseria meningitidis].
    Skoczyńska A; Hryniewicz W
    Pol Merkur Lekarski; 2003 Nov; 15(89):459-62. PubMed ID: 14969144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of mild systemic meningococcal disease with characterization of bacterial isolates.
    Edwards KM; Jones LM; Stephens DS
    Clin Pediatr (Phila); 1985 Nov; 24(11):617-20. PubMed ID: 3931950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase variation of DNA methyltransferases and the regulation of virulence and immune evasion in the pathogenic Neisseria.
    Seib KL; Jen FE; Scott AL; Tan A; Jennings MP
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections.
    John CM; Phillips NJ; Stein DC; Jarvis GA
    Pathog Dis; 2017 Apr; 75(3):. PubMed ID: 28423169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus.
    Pratt AJ; DiDonato M; Shin DS; Cabelli DE; Bruns CK; Belzer CA; Gorringe AR; Langford PR; Tabatabai LB; Kroll JS; Tainer JA; Getzoff ED
    J Bacteriol; 2015 Dec; 197(24):3834-47. PubMed ID: 26459556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meningococcal meningitis in Spain (1978-1981). III. Susceptibility of the meningococcal strains isolated from patients and carriers to the main agents used in the treatment and chemoprophylaxis of meningococcal infections].
    Sáez Nieto JA; Vázquez J; Casal J
    Rev Sanid Hig Publica (Madr); 1983; 57(5-6):587-602. PubMed ID: 6422536
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular colonization by Neisseria meningitidis.
    Melican K; Dumenil G
    Curr Opin Microbiol; 2012 Feb; 15(1):50-6. PubMed ID: 22185907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcemia Due to Nongroupable Neisseria meningitidis in a Splenectomized Child.
    Polat M; Parlakay AÖ
    Pediatr Infect Dis J; 2020 May; 39(5):e57. PubMed ID: 32301925
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of the clinical course of meningococcal infection in relation to the serogroup of the causative agent].
    Pokrovskiĭ VI; Lisukova TE; Demina AA; Tumanov FA; Kashin AM
    Sov Med; 1987; (8):85-7. PubMed ID: 3122333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.